Author
Axel F. Sigurðsson
Also Known As
A Sigurdsson, A. SIGURDSSON, A. Sigurdsson, Axel F Sigurdsson, Axel F Sigurðsson, Axel F. Sigurdsson, Axel F. Sigurðsson, Axel Sigurdsson, Hjartamiðstöðinni, Holtasmára 1, 201 Kópavogi, Iceland, Robert Gabor Kiss
44
Publications
3.2K
Citations
17
H-Index
38
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 7 | 7 | 2.4K |
2 | Health Sciences | 1 | 1 | 35 |
3 | Public Health | 1 | 1 | 28 |
4 | Allergy | 1 | 1 | 1.3K |
5 | Emergency Medicine | 1 | 1 | 18 |
Axel F. Sigurðsson
×
10
Publications
2.9K
Citations
10
H-Index
| Year | Citations | |
|---|---|---|
2017 | 1.3K | |
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Paul M. Ridker, Jean MacFadyen, Peter Libby, Cardiovascular ToxicityC-reactive Protein ReductionCardiovascular DiseaseCardiovascular PharmacologyEvent Reduction | 2017 | 847 |
2005 | 233 | |
2005 | 165 | |
1993 | 133 | |
1989 | 71 | |
1996 | 68 | |
2009 | 35 | |
2014 | 28 | |
1991 | 18 |
Page 1
Page 1